A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00853099 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL: adalimumab
DRUG: placebo

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]